Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

20.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RWHMDA: Random Walk on Hypergraph for Microbe-Disease Association Prediction.

Frontiers in microbiology·2019
Same author

Integrating random walk and binary regression to identify novel miRNA-disease association.

BMC bioinformatics·2019
Same author

Maximal entropy random walk on heterogenous network for MIRNA-disease Association prediction.

Mathematical biosciences·2018
Same author

SSCMDA: spy and super cluster strategy for MiRNA-disease association prediction.

Oncotarget·2018
Same author

GIMDA: Graphlet interaction-based MiRNA-disease association prediction.

Journal of cellular and molecular medicine·2017
Same author

A novel approach based on KATZ measure to predict associations of human microbiota with non-infectious diseases.

Bioinformatics (Oxford, England)·2017

Related Experiment Video

Updated: Apr 27, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.5K

Semi-supervised learning for potential human microRNA-disease associations inference.

Xing Chen1, Gui-Ying Yan1

  • 11] National Center for Mathematics and Interdisciplinary Sciences, Chinese Academy of Sciences, Beijing, 100190, China [2] Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, 100190, China.

Scientific Reports
|July 1, 2014
PubMed
Summary

We developed a new method, Regularized Least Squares for MiRNA-Disease Association (RLSMDA), to predict microRNA-disease relationships. This approach accurately identifies potential associations, even for diseases with unknown related microRNAs, aiding biomedical research.

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

552
Identifying Targets of Human microRNAs with the LightSwitch Luciferase Assay System using 3'UTR-reporter Constructs and a microRNA Mimic in Adherent Cells
07:19

Identifying Targets of Human microRNAs with the LightSwitch Luciferase Assay System using 3'UTR-reporter Constructs and a microRNA Mimic in Adherent Cells

Published on: September 28, 2011

38.0K

Related Experiment Videos

Last Updated: Apr 27, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.5K
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

552
Identifying Targets of Human microRNAs with the LightSwitch Luciferase Assay System using 3'UTR-reporter Constructs and a microRNA Mimic in Adherent Cells
07:19

Identifying Targets of Human microRNAs with the LightSwitch Luciferase Assay System using 3'UTR-reporter Constructs and a microRNA Mimic in Adherent Cells

Published on: September 28, 2011

38.0K

Area of Science:

  • Biomedical research
  • Bioinformatics
  • Genomics

Background:

  • MicroRNAs (miRNAs) are crucial in disease development and progression.
  • Predicting miRNA-disease associations is vital but challenging due to data complexity.
  • Existing methods have limitations in handling novel or sparsely documented associations.

Purpose of the Study:

  • To develop a novel computational method for predicting miRNA-disease associations.
  • To address limitations of existing methods, including handling diseases with no prior miRNA associations.
  • To provide a robust tool for uncovering complex relationships between miRNAs and diseases.

Main Methods:

  • Developed Regularized Least Squares for MiRNA-Disease Association (RLSMDA), a semi-supervised, global prediction method.
  • RLSMDA does not require negative samples and prioritizes associations for all diseases simultaneously.
  • Validated performance using leave-one-out cross-validation and calculated Area Under the Curve (AUC).

Main Results:

  • RLSMDA demonstrated reliable performance with high AUC values.
  • Applied to Hepatocellular cancer and Lung cancer, achieving 80% and 84% confirmation rates for top predicted miRNAs, respectively.
  • Successfully predicted 34 novel miRNA-disease associations for diseases lacking prior experimental data.

Conclusions:

  • RLSMDA is an effective and reliable method for predicting miRNA-disease associations.
  • The tool can identify potential associations for diseases with limited or no existing data.
  • RLSMDA offers a valuable bioinformatics resource for advancing biomedical research and disease understanding.